Skip to Content
Interactive Textbook on Clinical Symptom Research Logo


Home Button

Clinical Trials in TMD Sections
Author Bio
Introduction
The Biopsychosocial Model
Designing Multicenter RCTs
Players in an RCT
Randomization
Trial Design Quality
TMD Case Definition
Endpoints and Outcome Measures
Blinding & Masking
Study Sample Size
Number and Nature of Interventions
Study Length and Follow up
Intent-to-treat Analyses and Sample Size
Compliance
Multicenter RCTs
Implementing RCTs: Practical Issues
Currently selected section: Analysis of TMD Trials
Conclusions
Acknowledgments
Appendix A
Appendix B

 

Chapter 22: Clinical Trials in Temporomandibular: Analysis of TMD Trials
        

Intent to Treat Analyses

As we have previously discussed, intent to treat primary analyses are a virtual requirement for publication in peer-reviewed journals, again, because they are least likely to be biased and are usually conservative in the magnitude of any treatment effects measured.

There are newer alternatives to intent to treat analyses (Goetghebeur and Loeys, 2002), and many investigators now believe it is acceptable to present analyses that show both 1) intent to treat and 2) "per the protocol", that is, analyses reflecting what patients actually received (Peduzzi et al., 2002; Whitney, C.W. and Dworkin, S.F. Practical implications of noncompliance in randomized clinical trials for temporomandibular disorders. Journal of Orofacial Pain, 11:130-138, 1997). In this way, the readers can decide for themselves the effect of participants not completing the original treatment that was assigned.

Even so, the preferred approach is to do everything possible to maximize retention of all patients who were randomized into receiving the correct interventions, collect data on them through all the follow-ups, and report intent-to-treat analyses.

 

 


Page 69 of 81
      Previous Page